X

Vous n'êtes pas connecté

Rubriques :

  - WORLDSTAGENEWS.COM - A La Une - Hier 15:49

WHO issues landmark policy action to reshape global HIV response

The World Health Organisation (WHO) on Monday released a landmark policy, recommending the use of injectable Lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. The organisation in a statement said  the guidelines were issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, Rwanda. “LEN, the first twice-yearly injectable PrEP product, offers a highly effective, long-acting alternative to daily oral pills and other shorter-acting options. “With just two doses per year, LEN is a transformative step forward in…

Articles similaires

Sorry! Image not available at this time

WHO recommends injectable lenacapavir for HIV prevention

caribbeannewsglobal.com - 17:04

 GENEVA, Switzerland – The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a...

Sorry! Image not available at this time

WHO guidelines endorse Gilead’s HIV injection

observer24.com.na - 21:02

The director-general of the World Health Organisation (WHO), Tedros Ghebreyesus, has endorsed new WHO guidelines recommending long-acting injectable...

Sorry! Image not available at this time

WHO guidelines endorse Gilead’s HIV injection

observer24.com.na - 21:02

The director-general of the World Health Organisation (WHO), Tedros Ghebreyesus, has endorsed new WHO guidelines recommending long-acting injectable...

Sorry! Image not available at this time

MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access, including licensing limitations

wn.com - 07:22

MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access,...

Sorry! Image not available at this time

MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access, including licensing limitations

wn.com - 07:22

MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access,...

Sorry! Image not available at this time

Cambodia Leads Asia in Long-Acting HIV Prevention Rollout

medindia.net - 08/Jul 12:01

Cambodia is now the second country in Asia, following Thailand, to initiate long-acting injectable medlinkpre-exposure prophylaxis (PrEP)/medlink to...

Sorry! Image not available at this time

WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight

wn.com - 20:00

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their...

Sorry! Image not available at this time

Cambodia Leads Asia in Long-Acting HIV Prevention Rollout

medindia.net - 08/Jul 12:01

Cambodia becomes Asia's second nation to launch long-acting injectable PrEP for HIV prevention, marking strong progress toward ending AIDS.

Sorry! Image not available at this time

News24 | SA gets R520m to buy the twice-a-year anti-HIV jab... but there’s a snag

news24.com - 20:09

South Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and Malaria to buy the...

Sorry! Image not available at this time

Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV ...

wn.com - 09/Jul 16:58

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD)...

Les derniers communiqués